Heart failure Symptomatic New York Heart Association Classification | Diabetes Mellitus, Non-Insulin-Dependent
Item
all subjects with physician-diagnosed symptomatic heart failure (nyha class i, ii, iii, iv) and type 2 diabetes.
boolean
C0018801 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C1275491 (UMLS CUI [1,3])
C0011860 (UMLS CUI [2])
Non-Insulin-Dependent Diabetes Mellitus Definition
Item
a diagnosis of type 2 diabetes defined as:
boolean
C0011860 (UMLS CUI [1,1])
C1704788 (UMLS CUI [1,2])
Non-Insulin-Dependent Diabetes Mellitus Medical Record
Item
a previous physician diagnosis of type 2 diabetes as documented in the subject's clinical record or;
boolean
C0011860 (UMLS CUI [1,1])
C0025102 (UMLS CUI [1,2])
Hypoglycemic Agents Oral
Item
receiving oral antihyperglycemic agents or;
boolean
C0020616 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
Non-Insulin-Dependent Diabetes Mellitus New diagnosis | Fasting blood glucose measurement | Random blood glucose measurement
Item
a new diagnosis of type 2 diabetes during the visit within the heart failure clinic or hospital based on a fasting blood glucose ≥7.0 mmol/l or random blood glucose
boolean
C0011860 (UMLS CUI [1,1])
C2585997 (UMLS CUI [1,2])
C0428568 (UMLS CUI [2])
C0428567 (UMLS CUI [3])
Acute metabolic decompensation | Plasma Glucose Measurement | Oral Glucose Tolerance Test
Item
≥11.1 mmol/l accompanied by acute metabolic decompensation or 2 hour plasma glucose in a 75 gram oral glucose tolerance test ≥11.1 mmol/l.
boolean
C2673978 (UMLS CUI [1])
C0202042 (UMLS CUI [2])
C0029161 (UMLS CUI [3])
Metformin U/day
Item
subjects currently receiving greater than 1500 mg of metformin therapy per day
boolean
C0025598 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
Antidiabetics Change Unwilling
Item
subjects who are unwilling to change their antidiabetic regimens;
boolean
C0935929 (UMLS CUI [1,1])
C0392747 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
Insulin regime
Item
subjects receiving insulin therapy;
boolean
C0557978 (UMLS CUI [1])
Creatinine measurement, serum
Item
serum creatinine ≥ 180 μmol/l;
boolean
C0201976 (UMLS CUI [1])
Glycosylated hemoglobin A Percentage
Item
a1c < 7.0 percent;
boolean
C0019018 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
Able to communicate | Language Barrier
Item
inability to communicate (language barrier);
boolean
C2364293 (UMLS CUI [1])
C0237167 (UMLS CUI [2])
Dementia | Mental disorder
Item
dementia/mental illness;
boolean
C0497327 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
Age
Item
age < 18 years;
boolean
C0001779 (UMLS CUI [1])
Blood Glucose Self-Monitoring Completion Unwilling
Item
subjects unwilling to complete self-monitoring of serum blood sugars during the trial period.
boolean
C0005803 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
Study Subject Participation Status | Investigational New Drugs | Heart failure | Diabetes Mellitus
Item
those participating in another heart failure or diabetes clinical trial involving medication;
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C0018801 (UMLS CUI [3])
C0011849 (UMLS CUI [4])
Comorbidity Severe | Life Expectancy Shortened
Item
severe comorbidities or foreshortened life expectancy;
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0023671 (UMLS CUI [2,1])
C1282927 (UMLS CUI [2,2])
Informed Consent Missing
Item
subjects who do not provide written informed consent to participate.
boolean
C0021430 (UMLS CUI [1,1])
C1705492 (UMLS CUI [1,2])